DOSTARLIMAB vs DOXORUBICIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DOSTARLIMAB vs DOXORUBICIN: Safety Overview
| Metric | DOSTARLIMAB | DOXORUBICIN |
|---|---|---|
| Total FAERS Reports | 893 | 82,754 |
| Deaths Reported | 130 | 15,653 |
| Death Rate | 14.6% | 18.9% |
| Hospitalizations | 441 | 28,630 |
| Average Patient Age | 65.8 yrs | 50.5 yrs |
| % Female Patients | 91.6% | 53.9% |
| FDA Approval Date | N/A | Approved Prior to Jan 1, 1982 |
| Manufacturer | GlaxoSmithKline LLC | Hikma Pharmaceuticals USA Inc. |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | N/A | Discontinued |